Caroline Arber

1.0k total citations
30 papers, 762 citations indexed

About

Caroline Arber is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Caroline Arber has authored 30 papers receiving a total of 762 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 15 papers in Immunology and 10 papers in Molecular Biology. Recurrent topics in Caroline Arber's work include CAR-T cell therapy research (21 papers), Immune Cell Function and Interaction (10 papers) and Virus-based gene therapy research (9 papers). Caroline Arber is often cited by papers focused on CAR-T cell therapy research (21 papers), Immune Cell Function and Interaction (10 papers) and Virus-based gene therapy research (9 papers). Caroline Arber collaborates with scholars based in United States, Switzerland and France. Caroline Arber's co-authors include Jan A. Rath, Lionel Trueb, Benita Wolf, George Coukos, Cynthia Pérez, Patrick Barth, Andrew BitMansour, Malcolm K. Brenner, Stephen Gottschalk and Stefan Zimmermann and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Caroline Arber

27 papers receiving 753 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Caroline Arber United States 16 504 343 235 164 132 30 762
Leo D. Wang United States 13 396 0.8× 330 1.0× 336 1.4× 116 0.7× 139 1.1× 25 924
Marc Wehrli United States 12 363 0.7× 399 1.2× 360 1.5× 100 0.6× 109 0.8× 24 830
Sanfang Tu China 16 582 1.2× 201 0.6× 297 1.3× 154 0.9× 144 1.1× 52 858
Anthony F. Daniyan United States 12 784 1.6× 363 1.1× 326 1.4× 237 1.4× 241 1.8× 24 1.0k
Namiko Okuyama Japan 6 747 1.5× 467 1.4× 285 1.2× 163 1.0× 208 1.6× 9 945
James Dongjoo Ham United States 6 643 1.3× 550 1.6× 210 0.9× 96 0.6× 132 1.0× 9 832
Tatsunori Goto Japan 14 435 0.9× 240 0.7× 216 0.9× 146 0.9× 163 1.2× 48 723
Lekha Mikkilineni United States 12 783 1.6× 236 0.7× 400 1.7× 157 1.0× 197 1.5× 26 980
Liqing Kang China 19 722 1.4× 188 0.5× 316 1.3× 204 1.2× 246 1.9× 68 944
Babak Moghimi United States 14 474 0.9× 195 0.6× 493 2.1× 399 2.4× 125 0.9× 23 1.0k

Countries citing papers authored by Caroline Arber

Since Specialization
Citations

This map shows the geographic impact of Caroline Arber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caroline Arber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caroline Arber more than expected).

Fields of papers citing papers by Caroline Arber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caroline Arber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caroline Arber. The network helps show where Caroline Arber may publish in the future.

Co-authorship network of co-authors of Caroline Arber

This figure shows the co-authorship network connecting the top 25 collaborators of Caroline Arber. A scholar is included among the top collaborators of Caroline Arber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caroline Arber. Caroline Arber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bartolini, Robin, Lionel Trueb, Douglas Daoudlarian, et al.. (2025). Enrichment of CD7+CXCR3+ CAR T-cells in infusion products is associated with durable remission in relapsed or refractory diffuse large B-cell lymphoma. Annals of Oncology. 36(7). 749–761. 1 indexed citations
2.
Trueb, Lionel, et al.. (2025). Novel strategies to manage CAR-T cell toxicity. Nature Reviews Drug Discovery. 24(5). 379–397. 18 indexed citations
3.
Santamaria‐Martínez, Albert, Natalya Katanayeva, Luc Reymond, et al.. (2024). Antibody–peptide conjugates deliver covalent inhibitors blocking oncogenic cathepsins. Nature Chemical Biology. 20(9). 1188–1198. 14 indexed citations
4.
Spertini, Olivier, Alexandre P. Bénéchet, Mónica Román-Trufero, et al.. (2024). Macrophage migration inhibitory factor blockade reprograms macrophages and disrupts prosurvival signaling in acute myeloid leukemia. Cell Death Discovery. 10(1). 157–157. 8 indexed citations
5.
Jaccard, Alison, Tania Wyss, Noelia Maldonado‐Pérez, et al.. (2023). Reductive carboxylation epigenetically instructs T cell differentiation. Nature. 621(7980). 849–856. 71 indexed citations
6.
Roberts, Jefferson, et al.. (2023). Computational design of dynamic receptor—peptide signaling complexes applied to chemotaxis. Nature Communications. 14(1). 2875–2875. 9 indexed citations
7.
Omer, Bilal, Thomas Pfeiffer, Sandhya Sharma, et al.. (2022). A Costimulatory CAR Improves TCR-based Cancer Immunotherapy. Cancer Immunology Research. 10(4). 512–524. 19 indexed citations
8.
Cairoli, Anne, et al.. (2022). Significant Progress in CAR T-Cell Therapy for Difficult-to-Treat Hematologic Malignancies. SHILAP Revista de lepidopterología.
9.
Bajwa, Gagan & Caroline Arber. (2022). Rapid Generation of TCR and CD8αβ Transgenic Virus Specific T Cells for Immunotherapy of Leukemia. Frontiers in Immunology. 13. 830021–830021. 3 indexed citations
10.
Pérez, Cynthia, et al.. (2020). Off-the-Shelf Allogeneic T Cell Therapies for Cancer: Opportunities and Challenges Using Naturally Occurring “Universal” Donor T Cells. Frontiers in Immunology. 11. 583716–583716. 43 indexed citations
11.
Wolf, Benita, Stefan Zimmermann, Caroline Arber, et al.. (2019). Safety and Tolerability of Adoptive Cell Therapy in Cancer. Drug Safety. 42(2). 315–334. 63 indexed citations
12.
Brenner, Daniel, Malini Mukherjee, Rachel Hirsch, et al.. (2017). c-MPL provides tumor-targeted T-cell receptor-transgenic T cells with costimulation and cytokine signals. Blood. 130(25). 2739–2749. 9 indexed citations
13.
Velasquez, Mireya Paulina, David Torres, Kota Iwahori, et al.. (2016). T cells expressing CD19-specific Engager Molecules for the Immunotherapy of CD19-positive Malignancies. Scientific Reports. 6(1). 27130–27130. 45 indexed citations
14.
Bonifant, Challice L., Árpád Szöőr, David Torres, et al.. (2016). CD123-Engager T Cells as a Novel Immunotherapeutic for Acute Myeloid Leukemia. Molecular Therapy. 24(9). 1615–1626. 68 indexed citations
15.
Arber, Caroline, Xiang Feng, Harshal Abhyankar, et al.. (2014). Survivin-specific T cell receptor targets tumor but not T cells. Journal of Clinical Investigation. 125(1). 157–168. 55 indexed citations
16.
Arber, Caroline, Harshal Abhyankar, Helen E. Heslop, et al.. (2013). The immunogenicity of virus-derived 2A sequences in immunocompetent individuals. Gene Therapy. 20(9). 958–962. 26 indexed citations
17.
Arber, Caroline, Xiang Feng, Harshal Abhyankar, et al.. (2013). A “non-fratricidal” αβ- T Cell Receptor That Targets Survivin Expressed By Hematological Malignancies. Blood. 122(21). 141–141.
18.
Arber, Caroline, Jörg Halter, M. Stern, et al.. (2010). Graft source determines human hematopoietic progenitor distribution pattern within the CD34+ compartment. Bone Marrow Transplantation. 46(5). 650–658. 10 indexed citations
19.
Arber, Caroline, et al.. (2005). Protection against LethalAspergillus fumigatusInfection in Mice by Allogeneic Myeloid Progenitors Is Not Major Histocompatibility Complex Restricted. The Journal of Infectious Diseases. 192(9). 1666–1671. 21 indexed citations
20.
Schulz, Stephan, Caroline Arber, Jeanette Baker, et al.. (2005). Ex Vivo Expanded Dendritic Cells Home to T-Cell Zones of Lymphoid Organs and Survive in Vivo after Allogeneic Bone Marrow Transplantation. American Journal Of Pathology. 167(5). 1321–1331. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Leo D. Wang Breakdown of academic impact, for papers by Marc Wehrli Breakdown of academic impact, for papers by Sanfang Tu Breakdown of academic impact, for papers by Anthony F. Daniyan Breakdown of academic impact, for papers by Namiko Okuyama Breakdown of academic impact, for papers by James Dongjoo Ham Breakdown of academic impact, for papers by Tatsunori Goto Breakdown of academic impact, for papers by Lekha Mikkilineni Breakdown of academic impact, for papers by Liqing Kang Breakdown of academic impact, for papers by Babak Moghimi
Rankless by CCL
2026